Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
J Immunother ; 33(8): 848-58, 2010 Oct.
Article in English | MEDLINE | ID: mdl-20842051

ABSTRACT

Induction of cytotoxic CD8 T-cell responses is enhanced by the exclusive presentation of antigen through dendritic cells, and by innate stimuli, such as toll-like receptor ligands. On the basis of these 2 principles, we designed a vaccine against melanoma. Specifically, we linked the melanoma-specific Melan-A/Mart-1 peptide to virus-like nanoparticles loaded with A-type CpG, a ligand for toll-like receptor 9. Melan-A/Mart-1 peptide was cross-presented, as shown in vitro with human dendritic cells and in HLA-A2 transgenic mice. A phase I/II study in stage II-IV melanoma patients showed that the vaccine was well tolerated, and that 14/22 patients generated ex vivo detectable T-cell responses, with in part multifunctional T cells capable to degranulate and produce IFN-γ, TNF-α, and IL-2. No significant influence of the route of immunization (subcutaneous versus intradermal) nor dosing regimen (weekly versus daily clusters) could be observed. It is interesting to note that, relatively large fractions of responding specific T cells exhibited a central memory phenotype, more than what is achieved by other nonlive vaccines. We conclude that vaccination with CpG loaded virus-like nanoparticles is associated with a human CD8 T-cell response with properties of a potential long-term immune protection from the disease.


Subject(s)
CD8-Positive T-Lymphocytes/metabolism , Cancer Vaccines , Melanoma/therapy , Skin Neoplasms/therapy , T-Lymphocyte Subsets/metabolism , Vaccines, Virus-Like Particle , Adult , Aged , Animals , CD8-Positive T-Lymphocytes/immunology , CD8-Positive T-Lymphocytes/pathology , Cell Differentiation , Cells, Cultured , Female , HLA-A2 Antigen/genetics , HLA-A2 Antigen/metabolism , Humans , Immunologic Memory , Lymphocyte Activation , MART-1 Antigen/chemistry , MART-1 Antigen/immunology , Male , Melanoma/immunology , Melanoma/pathology , Melanoma/physiopathology , Mice , Mice, Transgenic , Middle Aged , Nanoparticles/chemistry , Oligodeoxyribonucleotides/chemistry , Oligodeoxyribonucleotides/immunology , Peptide Fragments/chemistry , Peptide Fragments/immunology , Skin Neoplasms/immunology , Skin Neoplasms/pathology , Skin Neoplasms/physiopathology , T-Lymphocyte Subsets/immunology , T-Lymphocyte Subsets/pathology , Treatment Outcome
2.
Arch Dermatol ; 140(9): 1109-15, 2004 Sep.
Article in English | MEDLINE | ID: mdl-15381552

ABSTRACT

OBJECTIVES: To verify the diagnostic value of lumbosacral midline cutaneous lesions in asymptomatic children to detect occult spinal dysraphism (OSD) and to propose a practical approach for clinical investigations with respect to the type of cutaneous lesions observed. DESIGN: Retrospective study of 54 children referred to the Department of Pediatric Dermatology between 1990 and 1999 for congenital midline lumbosacral cutaneous lesions. SETTING: The private or institutional practices of participating dermatologists and pediatricians. MAIN OUTCOME MEASURES: Evaluation of the diagnostic value of midline cutaneous lesions for the detec-tion of OSD. Association of skin examination findings with spinal anomalies detected by magnetic resonance imaging or ultrasound. RESULTS: Occult spinal dysraphism was detected in 3 of 36 patients with an isolated congenital midline lesion and 11 of 18 patients with a combination of 2 or more different skin lesions. CONCLUSIONS: A combination of 2 or more congenital midline skin lesions is the strongest marker of OSD. Careful dermatologic examination is needed to detect suggestive markers and request a spinal magnetic resonance image, which is the most sensitive radiologic approach to detect an OSD.


Subject(s)
Skin Abnormalities/diagnosis , Spina Bifida Occulta/diagnosis , Adolescent , Child , Child, Preschool , Female , Hemangioma, Capillary/congenital , Hemangioma, Capillary/diagnosis , Humans , Infant , Infant, Newborn , Magnetic Resonance Imaging , Male , Port-Wine Stain/diagnosis , Prognosis , Retrospective Studies , Sensitivity and Specificity , Skin Abnormalities/surgery , Spina Bifida Occulta/surgery , Spinal Dysraphism/diagnosis , Spinal Dysraphism/surgery , Treatment Outcome , Ultrasonography, Doppler
3.
Melanoma Res ; 13(5): 511-20, 2003 Oct.
Article in English | MEDLINE | ID: mdl-14512793

ABSTRACT

The technique of sentinel lymph node (SLN) dissection is a reliable predictor of metastatic disease in the lymphatic basin draining the primary melanoma. Reverse transcription-polymerase chain reaction (RT-PCR) is emerging as a highly sensitive technique to detect micrometastases in SLNs, but its specificity has been questioned. A prospective SLN study in melanoma patients was undertaken to compare in detail immunopathological versus molecular detection methods. Sentinel lymphadenectomy was performed on 57 patients, with a total of 71 SLNs analysed. SLNs were cut in slices, which were alternatively subjected to parallel multimarker analysis by microscopy (haematoxylin and eosin and immunohistochemistry for HMB-45, S100, tyrosinase and Melan-A/MART-1) and RT-PCR (for tyrosinase and Melan-A/MART-1). Metastases were detected by both methods in 23% of the SLNs (28% of the patients). The combined use of Melan-A/MART-1 and tyrosinase amplification increased the sensitivity of PCR detection of microscopically proven micrometastases. Of the 55 immunopathologically negative SLNs, 25 were found to be positive on RT-PCR. Notably, eight of these SLNs contained naevi, all of which were positive for tyrosinase and/or Melan-A/MART-1, as detected at both mRNA and protein level. The remaining 41% of the SLNs were negative on both immunohistochemistry and RT-PCR. Analysis of a series of adjacent non-SLNs by RT-PCR confirmed the concept of orderly progression of metastasis. Clinical follow-up showed disease recurrence in 12% of the RT-PCR-positive immunopathology-negative SLNs, indicating that even an extensive immunohistochemical analysis may underestimate the presence of micrometastases. However, molecular analyses, albeit more sensitive, need to be further improved in order to attain acceptable specificity before they can be applied diagnostically.


Subject(s)
Lymphatic Metastasis , Melanoma/diagnosis , Melanoma/pathology , Skin Neoplasms/diagnosis , Skin Neoplasms/pathology , Biomarkers, Tumor , Female , Humans , Immunohistochemistry , Male , Monophenol Monooxygenase/metabolism , Neoplasm Metastasis , RNA/chemistry , Reverse Transcriptase Polymerase Chain Reaction , Sentinel Lymph Node Biopsy/methods , Treatment Outcome
5.
Skin Res Technol ; 8(4): 240-9, 2002 Nov.
Article in English | MEDLINE | ID: mdl-12423543

ABSTRACT

PURPOSE: This study aims at evaluating two automatic contour detection techniques especially developed for dermoscopic images. METHODS: Twenty-five images of lesions with a fuzzy boundary have been randomly selected. Five dermatologists experienced in dermoscopy have manually drawn the border of all the lesions and repeated the procedure after two and four weeks. The ability of a dermatologist to reproduce its own results was evaluated by measuring the non-overlapping area enclosed by its three successive contours. The interobserver variability evaluated the contour accuracy when using automatic or manual drawings. The mean probability that a pixel has been misclassified was computed for every observer and automatic technique. RESULTS: Experts in dermoscopy are not able to reproduce measurements precisely and the two automatic techniques had a lower misclassification probability than those obtained by each dermatologist. CONCLUSION: This study demonstrates that a single dermatologist should not be used as a reference, and subjective validation of lesion contour is inaccurate outside an experts's group. It is argued that image processing techniques for computer-aided diagnosis must show the best compromise within such a group.


Subject(s)
Diagnosis, Computer-Assisted/methods , Skin Diseases/pathology , Algorithms , Humans , Skin Pigmentation
SELECTION OF CITATIONS
SEARCH DETAIL
...